Common use of Use of Fund or Adviser Name by Insurer Clause in Contracts

Use of Fund or Adviser Name by Insurer. (a) The Insurer will furnish, or will cause to be furnished, to the Fund or the Adviser, each piece of sales literature or other promotional material in which the Fund or the Adviser is named, at least ten (10) Business Days prior to its use. No such material will be used if the Fund or the Adviser reasonably objects to such use within five (5) Business Days after receipt of such material. (b) The Insurer will not give any information or make any representations or statements on behalf of the Fund or concerning the Fund, in connection with the sale of Contracts other than the information or representations contained in a registration statement, prospectus or statement of additional information for Fund shares, as such registration statement, prospectus and statement of additional information may be amended or supplemented, from time to time, or in published reports for the Fund which are in the public domain or approved by the Fund or the Adviser for distribution, or in the sales literature or other material provided by the Fund, except with the permission of the Fund or the Adviser. The Fund and the Adviser agree to respond to any request for approval on a prompt and timely basis. Nothing in this Section will be construed as preventing the Insurer or its employees or agents from giving advice on investment in the Fund. (c) The Fund and the Adviser hereby consent to the Insurer's use of the name Alliance Capital Management L.P. and Alliance Variable Products Series Fund, Inc. and appropriate variations thereof in connection with the marketing the Contracts, subject to the terms of this Section. Such consent will terminate with the termination of this Agreement.

Use of Fund or Adviser Name by Insurer. (a) The Insurer will furnish, or will cause to be furnished, furnished to the Fund or the Adviser, each piece of sales literature or other promotional material in which the Fund or the Adviser is named, at least ten (10) Business Days prior to its use. No such material will be used if the Fund or the Adviser reasonably objects to such use within five (5) Business Days after receipt of such material. (b) The Insurer will not give any information or make any representations or statements on behalf of the Fund or concerning the Fund, in connection with the sale of Contracts other than the information or representations contained in a registration statement, prospectus or statement of additional information for Fund shares, as such registration statement, statement prospectus and statement of additional information may be amended or supplemented, from time to time, or in published reports for the Fund which are in the public domain or approved by the Fund or the Adviser for distribution, or in the sales literature or other material provided by the Fund, except with the permission of the Fund or the Adviser. The Fund and the Adviser agree to respond to any request for approval on a prompt and timely basis. Nothing in this Section will be construed as preventing the Insurer or its employees or agents from giving advice on investment in the Fund. (c) The Fund and the Adviser hereby consent to the Insurer's use of the name Alliance Capital Management AllianceBernstein L.P. and Alliance AllianceBernstein Variable Products Series Fund, Inc. and appropriate variations thereof in connection with the marketing the Contracts, subject to the terms of this Section. Such consent will terminate with the termination of this Agreement.